JAK/STAT pathway interacts with intercellular cell adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM) while prostate cancer stem cells form tumor spheroids
dc.contributor.author | Duzagac F. | |
dc.contributor.author | Inan S. | |
dc.contributor.author | Simsek F.E. | |
dc.contributor.author | Acikgoz E. | |
dc.contributor.author | Guven U. | |
dc.contributor.author | Khan S.A. | |
dc.contributor.author | Rouhrazi H. | |
dc.contributor.author | Oltulu F. | |
dc.contributor.author | Aktug H. | |
dc.contributor.author | Erol A. | |
dc.contributor.author | Oktem G. | |
dc.date.accessioned | 2024-07-22T08:12:59Z | |
dc.date.available | 2024-07-22T08:12:59Z | |
dc.date.issued | 2015 | |
dc.description.abstract | Purpose: JAK/STAT is an evolutionarily conserved pathway and very important for second messenger system. This pathway is important in malignant transformation and accumulated evidence indicates that this pathway is involved in tumorigenesis and progression of several cancers. It was possible to assume that activation of JAK/STAT pathway is associated with increase in the expressions of ICAM-1 and VCAM-1. In this study we hypothesized that when cells were maintained as spheroids or monolayers, the structure of cancer stem cells (CSCs) could show differentiation when compared with non-CSCs. Methods: DU-145 human prostate cancer cells were cultured using the Ege University molecular embryology laboratory medium supplemented with 10% fetal bovine serum. Clusters of differentiation 133 (CD133)(+high)/CD44(+high) prostate CSCs were isolated from the DU145 cell line by using BD FACSAria. CD133+/CD44+ CSCs were cultured until confluent with 3% noble agar. The expression of these proteins in CSCs and non-CSCs was analyzed by immunohistochemistry. Results: Different expression profiles were observed in the conventional two-dimensional (2D) and three-dimensional (3D) experimental model system when CSCs and non-CSCs were compared. Human prostate CSCs exhibited intense ICAM-1 and VCAM-1 immunoreaction when compared with non-CSCs. These findings were supported by the fact that VCAM-1 on the surface of cancer cells binds to its counterreceptor, the a4fil integrin (also known as very-late antigen, VLA-4), on metastasis-associated macrophages, triggering VCAM-1-mediated activation of the phosphoinositide 3-kinase growth and survival pathway in cancer cells. Conclusions: The results of this study showed that changes in JAK/STAT pathway are related with adhesion molecules and could affect cancer progression. | |
dc.identifier.issn | 11070625 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/16250 | |
dc.language.iso | English | |
dc.publisher | Zerbinis Publications | |
dc.subject | Cell Line, Tumor | |
dc.subject | Humans | |
dc.subject | Immunohistochemistry | |
dc.subject | Intercellular Adhesion Molecule-1 | |
dc.subject | Janus Kinases | |
dc.subject | Male | |
dc.subject | Neoplastic Stem Cells | |
dc.subject | Prostatic Neoplasms | |
dc.subject | Signal Transduction | |
dc.subject | Spheroids, Cellular | |
dc.subject | STAT Transcription Factors | |
dc.subject | Vascular Cell Adhesion Molecule-1 | |
dc.subject | CD133 antigen | |
dc.subject | Hermes antigen | |
dc.subject | intercellular adhesion molecule 1 | |
dc.subject | Janus kinase | |
dc.subject | Janus kinase 2 | |
dc.subject | phosphatidylinositol 3 kinase | |
dc.subject | STAT protein | |
dc.subject | STAT2 protein | |
dc.subject | STAT5 protein | |
dc.subject | vascular cell adhesion molecule 1 | |
dc.subject | very late activation antigen 4 | |
dc.subject | intercellular adhesion molecule 1 | |
dc.subject | Janus kinase | |
dc.subject | STAT protein | |
dc.subject | vascular cell adhesion molecule 1 | |
dc.subject | Article | |
dc.subject | cancer growth | |
dc.subject | cancer stem cell | |
dc.subject | cell differentiation | |
dc.subject | controlled study | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | human tissue | |
dc.subject | immunohistochemistry | |
dc.subject | macrophage | |
dc.subject | metastasis | |
dc.subject | molecular interaction | |
dc.subject | prostate cancer | |
dc.subject | protein expression | |
dc.subject | tumor spheroid | |
dc.subject | cancer stem cell | |
dc.subject | male | |
dc.subject | multicellular spheroid | |
dc.subject | pathology | |
dc.subject | physiology | |
dc.subject | prostate tumor | |
dc.subject | signal transduction | |
dc.subject | tumor cell line | |
dc.title | JAK/STAT pathway interacts with intercellular cell adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM) while prostate cancer stem cells form tumor spheroids | |
dc.type | Article |